Literature DB >> 22841388

Prevalence of mitral valve prolapse in residents living at moderately high altitude.

Tolga Sinan Güvenç1, Yiğit Canga, Yavuz Karabağ, Kaya Ozen, Bahattin Balcı.   

Abstract

OBJECTIVE: Prolapse of mitral valve leaflets is a frequent disorder and the most common cause of severe mitral regurgitation in western countries. However, little is known about the effects of altitude on mitral valve prolapse. We studied the prevalence and echocardiographic characteristics of mitral valve prolapse at moderately high altitude and sea level.
METHODS: A total of 936 consecutive subjects who were admitted to 2 study institutions at Kars, Turkey (1750 m) and Istanbul, Turkey (7 m) were enrolled in this study to determine prevalence of mitral valve prolapse. Demographic and 2-dimensional echocardiographic characteristics of participants were recorded.
RESULTS: Prevalence of mitral valve prolapse was found to be significantly higher in people living at moderate altitude compared with those living at sea level (6.2% vs 2.0%; P = .007). Overall echocardiographic features regarding valve thickness (4.1 ± 0.80 mm vs 3.6 ± 0.66 mm; P = 0.169), maximal valve prolapse (4.6 ± 2.08 mm vs 3.9 ± 0.91 mm; P = .093), and frequency of mitral regurgitation (89% vs 73%; P = .65) were similar between groups, although anterior valve prolapse was seen more frequently at moderate altitude (50% vs 11%; P = .056) and posterior leaflet prolapse was significantly more frequent at sea level (66% vs 10%; P = .002).
CONCLUSIONS: Mitral valve prolapse is more frequently observed at moderately high altitudes. Further studies are needed to determine clinical importance of our findings.
Copyright © 2012 Wilderness Medical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22841388     DOI: 10.1016/j.wem.2012.05.017

Source DB:  PubMed          Journal:  Wilderness Environ Med        ISSN: 1080-6032            Impact factor:   1.518


  1 in total

1.  Is there any link between joint hypermobility and mitral valve prolapse in patients with fibromyalgia syndrome?

Authors:  Erkan Kozanoglu; Ilke Coskun Benlidayi; Rabia Eker Akilli; Abdurrahman Tasal
Journal:  Clin Rheumatol       Date:  2015-07-28       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.